Gentamicin pharmacokinetics in old age and frailty

被引:41
|
作者
Hilmer, Sarah N. [1 ,2 ,3 ]
Tran, Kim [1 ,2 ,3 ]
Rubie, Patrick [1 ,2 ,3 ]
Wright, Jason [1 ,2 ,3 ]
Gnjidic, Danijela [1 ,2 ,3 ]
Mitchell, Sarah J. [1 ,2 ,3 ]
Matthews, Slade [3 ]
Carroll, Peter R. [3 ]
机构
[1] Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia
[2] Royal N Shore Hosp, Dept Aged Care, St Leonards, NSW 2065, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
关键词
age; frailty; gentamicin; pharmacokinetics; CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; PREDICTIVE PERFORMANCE; SERUM CREATININE; WEIGHT; DIET; ASSOCIATION; FORMULA; PATIENT;
D O I
10.1111/j.1365-2125.2010.03825.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
center dot Gentamicin pharmacokinetics show wide inter-individual variability across all age groups and impaired gentamicin clearance is associated with impaired creatinine clearance in older people. center dot Changes in body composition and renal function with old age and frailty are likely to affect the pharmacokinetics of gentamicin. center dot There is current debate on whether the Modification of Diet in Renal Disease (MDRD) equation estimate of glomerular filtration rate (GFR) should replace the Cockcroft Gault equation estimate of creatinine clearance for calculation of doses of renally excreted drugs. WHAT THIS STUDY ADDS center dot The volume of distribution of gentamicin is not significantly lower in frail than in non frail older people. center dot The correlation between volume of distribution of gentamicin and actual bodyweight is poor in frail and moderate in non frail older people. center dot Gentamicin clearance is significantly lower in frail than in non frail older people. center dot The Cockcroft Gault calculation of creatinine clearance, calculated using ideal bodyweight, gave the best estimate of gentamicin clearance in this population of frail and non frail older people. center dot The MDRD estimate of GFR and Cockcroft Gault estimate of creatinine clearance, calculated using actual bodyweight, overestimate gentamicin clearance in frail and non frail older people. AIMS Frailty, a syndrome of decreased physiological reserve that is prevalent in old age, impacts on clinical pharmacology. The aims of the study were to (1) determine whether frailty affects the pharmacokinetics of gentamicin and (2) assess the accuracy of different estimates of body size and renal clearance as estimates of gentamicin pharmacokinetics in older inpatients. METHODS This was an observational study of gentamicin pharmacokinetics in a cohort of Australian hospital inpatients aged >= 65 years, who were administered prophylactic intravenous gentamicin. RESULTS Of the 31 participants, 14 were frail and 17 non frail on the Reported Edmonton Frail Scale. The mean volume of distribution of gentamicin was 14.8 +/- 1.4 l in frail participants and 15.3 +/- 2.2 l in non frail (NS). Volume of distribution correlated best with lean bodyweight. Gentamicin clearance was significantly lower in frail participants (46.6 +/- 10.7 ml min-1) than in non frail (58.2 +/- 12.4 ml min-1, P = 0.01). The Cockcroft Gault estimate of creatinine clearance calculated using ideal bodyweight gave the best estimate of gentamicin clearance (mean error - 0.15 ml min-1, 95% CI -2.67, 2.39). The Cockcroft Gault creatinine clearance calculated using actual bodyweight and the estimated glomerular filtration rate from the modified diet in renal disease equation overestimated gentamicin clearance, with mean errors of -10.15 ml min-1 (95%CI -13.60, -6.71) and -18.86 ml min-1 (95% CI -22.45, -15.27), respectively. The Cockcroft Gault creatinine clearance calculated using lean bodyweight underestimated gentamicin clearance (mean error 6.54 ml min-1, 95% CI 4.18, 8.90). CONCLUSIONS Frail older people have significantly lower gentamicin clearance than non frail. The best estimate of gentamicin clearance is obtained from the Cockcroft Gault creatinine clearance calculated using ideal bodyweight.
引用
收藏
页码:224 / 231
页数:8
相关论文
共 50 条
  • [31] Frailty, disability and old age: A re-appraisal
    Gilleard, Chris
    Higgs, Paul
    HEALTH, 2011, 15 (05): : 475 - 490
  • [32] GENTAMICIN PHARMACOKINETICS IN KWASHIORKOR
    BUCHANAN, N
    DAVIS, MD
    EYBERG, C
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (05) : 451 - 453
  • [33] PHARMACOKINETICS OF GENTAMICIN IN RABBITS
    OGDEN, L
    WILSON, RC
    CLARK, CH
    COLBY, ED
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1995, 18 (02) : 156 - 159
  • [34] Pharmacokinetics of Opioid Analgesics in Old Age (PHOPA)
    Wustmann, S.
    Dettmer-Fluegge, A.
    Schmidt, D.
    Gogol, M.
    INTERNIST, 2013, 54 : 65 - 65
  • [35] Pharmacokinetics of gentamicin in llamas
    Dowling, PM
    Ferguson, JG
    Gibney, RF
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (02) : 161 - 163
  • [36] Pharmacokinetics of gentamicin in donkeys
    Welfare, RE
    Mealey, KL
    Matthews, NS
    Taylor, TS
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (02) : 167 - 169
  • [37] GENTAMICIN PHARMACOKINETICS - REPLY
    WAREHAM, DV
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (06): : 665 - 665
  • [38] Pharmacokinetics of Liposomal Gentamicin
    Rotov, K. A.
    Tikhonov, S. N.
    Alekseev, V. V.
    Snatenkov, E. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 153 (04) : 475 - 477
  • [39] PHARMACOKINETICS OF GENTAMICIN IN THE HORSE
    PEDERSOLI, WM
    BELMONTE, AA
    PUROHIT, RC
    RAVIS, WR
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1980, 41 (03) : 351 - 354
  • [40] Pharmacokinetics of Liposomal Gentamicin
    K. A. Rotov
    S. N. Tikhonov
    V. V. Alekseev
    E. A. Snatenkov
    Bulletin of Experimental Biology and Medicine, 2012, 153 : 475 - 477